Articles by Shim Woo-hyun
Shim Woo-hyun
ws@heraldcorp.com-
Conglomerates hesitant to hire
South Korean conglomerates are becoming more reluctant to finalize their hiring plans this year or downsize the number of new employees as their business prospects are shrouded in uncertainty, a poll on job recruiters showed on Thursday. Some 67 percent of conglomerates with over 1,000 employees confirmed that they have recruitment plans this year, falling for the third year in a row from 72 percent and 73 percent in 2023 and 2022, respectively, according to a report by online job portal Incruit
Industry Feb. 8, 2024
-
GNT Pharma partners with Pfizer for animal drug development
GNT Pharma said Monday that the company has signed an agreement with Pfizer's contract manufacturing arm for overseas production of the company’s veterinary medication GedaCure. Under the recent agreement, Pfizer CentreOne, which has production facilities in around 30 countries, will provide GNT Pharma with CDMO services in the countries, including the US and Europe, where GNT Pharma launches GedaCure. GedaCure is a chewable tablet of crisdesalazine and the world’s first multi-t
Industry Feb. 5, 2024
-
Korean dietary supplements makers eye Chinese market
South Korean dietary supplements manufacturers are accelerating their entries into the growing Chinese market as the number of elderly people continues to increase in the country, according to industry sources on Sunday. On the back of an aging population, the Chinese dietary supplements market grew 3 percent on-year to reach around 73 trillion won ($54.5 billion) in 2022, according to a report released by the Korea Trade-Investment Promotion Agency. Among Korean companies, Korea Ginseng Corp.,
Consumer Feb. 4, 2024
-
BAT names new Korean chief
BAT Rothmans, the Korean unit of British American Tobacco, announced Thursday that the company has appointed Song Young-jae, a BAT veteran, as its new country manager. The company said Song is a marketing and finance expert who will be tasked with promoting BAT’s combustible products. “Song is an expert in the global tobacco industry and the right person to spearhead the company’s future innovation,” an official from BAT Rothmans said. Graduated from the London School of
Industry Feb. 1, 2024
-
Kakao Healthcare plans to debut diabetes app in Japan
Kakao Healthcare, the digital health care unit under platform giant Kakao, on Thursday launched an artificial intelligence-based mobile blood sugar management service, PASTA, in Korea, hinting at plans for its overseas debuts in Japan and other countries. “Health care costs attributable to diabetes are increasing every year, and we aim to help reduce the costs through our new service," Kakao Healthcare CEO Hwang Hee said during a press conference at the company’s headquarters in
Industry Feb. 1, 2024
-
Posco, ADNOC to produce blue hydrogen in Gwangyang
Posco Group and the United Arab Emirates' Abu Dhabi National Oil Company will collaborate on blue hydrogen production facilities in Gwangyang, South Jeolla Province, Posco International said Wednesday. Posco International, Posco Holdings and ADNOC signed a three-way strategic collaboration agreement at the UAE energy group’s headquarters in Abu Dhabi. Under the agreement, the three companies will build blue hydrogen production facilities at Posco International’s liquefied natura
Industry Jan. 31, 2024
-
Samsung Biologics stocks extend rally on US bill
Samsung Biologics shares extended a rally Tuesday on upbeat sentiment that the company may be benefiting from US-proposed legislation that aims to restrict Chinese biotech firms from accessing the all-important American market. Last week, members of a bipartisan House Select Committee introduced a bill barring contracts with Beijing Genomics Institute and some Chinese biotech companies for their alleged connection with China’s People’s Liberation Army. The proposed bill specifically
Industry Jan. 30, 2024
-
[Herald Interview] Daewoong Pet targets health-conscious pet owners
Daewoong Pet, the pet health care arm of Daewoong Pharmaceutical, seeks to gain growth momentum by launching veterinary drugs and securing patent exclusivity as the need for veterinary care continues to surge amid an aging pet population. The firm's main aim is to develop and introduce drugs with the proper dosage and formulation for pets, with a particular focus on senior pets, which increasingly require health care services, Daewoong Pet co-CEO Lee Hyo-jun said. “Many veterinary hos
Industry Jan. 30, 2024
-
Celltrion seeks FDA approval for Actemra biosimilar
Celltrion has completed its submission of a biologics license application (BLA) to the US Food and Drug Administration for CT-P47, a biosimilar candidate mimicking Roche’s rheumatoid arthritis treatment Actemra (tocilizumab), the company said Monday. The BLA submission was based on results from the global phase 3 clinical trial involving 471 patients. In the clinical trial, the company tested the efficacy, pharmacokinetics, safety, and immunogenicity of CT-P47 compared to the reference pro
Industry Jan. 29, 2024
-
Genexine seeks approval for anemia treatment in Korea
Korean biotech firm Genexine announced Friday that the company has submitted a biologics license application to the country's Ministry of Food and Drug Safety for the company’s anemia treatment Efesa. Efesa is intended for the treatment and maintenance of anemia induced by chronic kidney disease with or without dialysis. The drug candidate uses GX-E4, a long-acting erythropoiesis stimulating agent. Genexine has used its own hyFc fusion protein technology to maximize the half-life of t
Industry Jan. 26, 2024
-
Cha Vaccine Institute develops its own mRNA delivery system
The Cha Vaccine Institute, a vaccine development arm of Cha Medical and Bio Group, has developed its own messenger RNA delivery system which does not require frozen storage, the company said Friday. The firm expects that Lipoplex would be a more efficient and stable option than lipid nanoparticles, which have been widely used as carriers for mRNA vaccines. Medicines utilizing mRNA have gained traction since the COVID-19 pandemic as they can be designed and produced quickly once the genome of the
Industry Jan. 26, 2024
-
CJ Olive Young, Kolmar team up on skin care
South Korean health and beauty retailer CJ Olive Young’s derma skin care brand Bioheal Boh and cosmetics and health care goods manufacturer Kolmar Korea have signed a business agreement to collaborate on microbiome skin care products. Under the recent agreement, the two companies will establish a new research lab, dubbed Probio Lab, to accelerate research and development of microbiome-based skin care products. “The latest business agreement is to combine Bioheal Boh’s specialti
Consumer Jan. 25, 2024
-
Samsung Biologics' profit exceeds W1tr for 1st time
Samsung Biologics’ annual operating profit topped 1 trillion won ($749 million) last year for the first time, according to the company’s regulatory filing on Wednesday. Its operating profit came to 1.14 trillion won last year, up 13 percent from the previous year. Sales also surged 23 percent during the same period. The sales figure, in particular, exceeded the full-year earnings guidance the company had announced earlier. The company previously anticipated sales to reach 3.60 trilli
Industry Jan. 24, 2024
-
Celltrion, China’s WuXi bolster ties on ADC partnership
Celltrion said Wednesday that the company has signed a business agreement with China’s WuXi XDC to accelerate its development of antibody-drug conjugates. WuXi XDC, a 60:40 joint venture between WuXi Biologics and WuXi STA, is a Chinese pharmaceutical company that provides contract research and development manufacturing organization services, mainly on ADCs and bioconjugates. The latest agreement is an extension of a contract development and manufacturing organization deal signed in Decemb
Industry Jan. 24, 2024
-
Beer sees steepest price hikes since 1998 financial crisis
Beer prices at restaurants saw the steepest price hikes last year since the 1998 financial crisis, according to the Korean Statistical Information Service on Tuesday. The consumer price index for beer products at restaurants increased to 114.66 points last year, up 6.9 percent from a year ago. The growth rate was the highest since the 1998 financial crisis when the CPI for beer soared by 9.7 percent. In the meantime, the prices of beer products sold at discount or convenience stores saw 2.9 perc
Consumer Jan. 23, 2024
Most Popular
-
1
Tensions heighten ahead of first president-opposition chief meeting
-
2
Seoul to provide housing subsidy to married couples with newborns
-
3
[KH Explains] No more 'Michael' at Kakao Games
-
4
Rapper jailed after public street fight with another rapper
-
5
Woman gets suspended term for injuring boyfriend with knife
-
6
Samsung chief bolsters ties with Germany’s Zeiss
-
7
NewJeans pops out ‘Bubble Gum’ video amid troubles at agency
-
8
[Grace Kao] Hybe vs. Ador: Inspiration, imitation and plagiarism
-
9
Med schools expect 1,500+ new admission slots next year
-
10
Nominee for chief of anti-corruption body pledges 'independence, effectiveness'